ArticlePreventive medicine reports2025
Evolution of the burden of disease for high BMI-associated colorectal cancer, 1990-2021: Global trends, regional heterogeneity, and population risk stratification.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Quantify global high body mass index (BMI)-linked colorectal cancer death and disability-adjusted life years (DALYs) (1990-2021) using the Global Burden of Disease (GBD) 2021 data, assessing spatiotemporal trends to inform prevention strategies. Methods: Geographic analysis, age-sex stratification, and sociodemographic index (SDI) quintiles evaluated disease distribution. Calculated estimated annual percentage change (EAPC) for trends. Demographic decomposition models quantified the contributions of population aging, epidemiological changes, and growth. Assessed health inequality via the slope inequality index (SII) and concentration index and prevention efficiency with SDI-age-standardized DALYs rate frontier. Results: Globally from 1990 to 2021, deaths from high BMI-associated colorectal cancer rose from 41,536 to 99,268, with the age-standardized death rate increasing from 1.14 to 1.17. The age-standardized death rate significantly increased in low- and middle-SDI regions while declining in high SDI regions. Disease burden growth was prominent in East and Southeast Asia. Death rates and rates of DALYs were higher in men than in women, and the burden was highest in people aged 60 years or older. Population growth was the primary driver of the increased burden (contributing >60 % to deaths and DALYs), followed by population aging. While health inequality (as measured by the SII) slightly decreased from 42.12 to 39.76, significant socio-demographic disparities persisted. Conclusion: High BMI-associated colorectal cancer burden escalates in low-middle SDI regions and elderly males. Targeted prevention and healthcare efficiency in low SDI areas are critical.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.